Insider Trading activities of Stemline Therapeutics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Stemline Therapeutics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Stemline Therapeutics Inc since year 2005. Table 2 shows the detailed insider transactions of Stemline Therapeutics Inc since 2005. The reporting company's ticker symbol is STML. The reporting company's CIK number is 1264587.
The total value of stock buying since 2005 is $108,268.
The total value of stock sales since 2005 is $3,053,171.
The total value of stock option exercises since 2005 is $258,393.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Stemline Therapeutics Inc (STML).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-03 0 $0 8,859 $72,093 0 $0
2017-02 0 $0 37,653 $260,300 0 $0
2017-01 0 $0 12,703 $167,075 0 $0
2016-03 0 $0 9,097 $48,554 0 $0
2016-02 0 $0 4,747 $21,291 0 $0
2016-01 0 $0 3,217 $15,499 0 $0
2015-11 0 $0 12,235 $100,326 0 $0
2015-04 0 $0 10,824 $170,694 0 $0
2015-03 0 $0 18,695 $306,728 32,526 $133,030
2015-02 0 $0 6,413 $89,859 0 $0
2015-01 0 $0 3,311 $47,082 0 $0
2014-11 0 $0 11,974 $172,425 0 $0
2014-09 5,000 $55,227 0 $0 0 $0
2014-05 0 $0 15,250 $203,130 0 $0
2014-04 0 $0 11,179 $171,653 0 $0
2013-11 0 $0 58,331 $1,206,462 112,940 $125,363
2013-05 3,000 $48,041 0 $0 0 $0
2013-01 500 $5,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Stemline Therapeutics Inc insiders (STML)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-03-07 Hoberman Kenneth (Chief Operating Officer) Sale 2,342 8.16 19,110
2017-03-07 Bergstein Ivan (Chief Executive Officer) Sale 5,401 8.13 43,910
2017-03-07 Gionco David (Chief Accounting Officer) Sale 1,116 8.13 9,073
2017-02-28 Hoberman Kenneth (Chief Operating Officer) Sale 4,027 7.01 28,229
2017-02-28 Bergstein Ivan (Chief Executive Officer) Sale 10,480 7.01 73,464
2017-02-28 Gionco David (Chief Accounting Officer) Sale 2,986 7.01 20,931
2017-02-27 Hoberman Kenneth (Chief Operating Officer) Sale 4,000 6.97 27,880
2017-02-27 Bergstein Ivan (Chief Executive Officer) Sale 7,500 6.97 52,275
2017-02-27 Gionco David (Chief Accounting Officer) Sale 3,500 6.97 24,395
2017-02-16 Hoberman Kenneth (Chief Operating Officer) Sale 1,508 6.42 9,681
2017-02-16 Bergstein Ivan (Chief Executive Officer) Sale 3,652 6.42 23,445
2017-01-19 Gionco David (Chief Accounting Officer) Sale 3,593 11.46 41,175
2017-01-10 Hoberman Kenneth (Chief Operating Officer) Sale 9,110 13.82 125,900
2016-03-08 Hoberman Kenneth (Chief Operating Officer) Sale 2,412 5.34 12,880
2016-03-08 Bergstein Ivan (Chief Executive Officer) Sale 5,537 5.34 29,567
2016-03-08 Gionco David (Chief Accounting Officer) Sale 1,148 5.32 6,107
2016-02-17 Hoberman Kenneth (Chief Operating Officer) Sale 1,503 4.54 6,823
2016-02-17 Bergstein Ivan (Chief Executive Officer) Sale 3,244 4.46 14,468
2016-01-20 Gionco David (Chief Accounting Officer) Sale 46 4.69 215
2016-01-19 Gionco David (Chief Accounting Officer) Sale 3,171 4.82 15,284
2015-11-30 Bergstein Ivan (Chief Executive Officer) Sale 12,235 8.20 100,326
2015-04-27 Rowinsky Eric K (Chief Medical Officer) Sale 10,824 15.77 170,694
2015-03-19 Hoberman Kenneth (Chief Operating Officer) Sale 17,307 16.43 284,354
2015-03-19 Hoberman Kenneth (Chief Operating Officer) Option Ex 27,105 4.09 110,859
2015-03-18 Bentsur Ron (Director) Sale 1,388 16.12 22,374
2015-03-18 Bentsur Ron (Director) Option Ex 5,421 4.09 22,171
2015-02-18 Hoberman Kenneth (Chief Operating Officer) Sale 1,593 14.02 22,333
2015-02-18 Bergstein Ivan (Chief Executive Officer) Sale 3,180 14.02 44,583
2015-02-18 Rowinsky Eric K (Chief Medical Officer) Sale 1,640 13.99 22,943
2015-01-20 Gionco David (Chief Accounting Officer) Sale 3,311 14.22 47,082
2014-11-26 Bergstein Ivan (Chief Executive Officer) Sale 11,974 14.40 172,425
2014-09-03 Bergstein Ivan (Chief Executive Officer) Buy 2,000 11.05 22,108
2014-09-02 Hoberman Kenneth (Chief Operating Officer) Buy 2,000 10.99 21,976
2014-09-02 Zuerblis Kenneth J (Director) Buy 1,000 11.14 11,143
2014-05-21 Hoberman Kenneth (Chief Operating Officer) Sale 15,250 13.32 203,130
2014-04-25 Rowinsky Eric K (Chief Medical Officer) Sale 11,179 15.36 171,653
2013-11-27 Hoberman Kenneth (Chief Operating Officer) Sale 15,411 19.91 306,833
2013-11-27 Hoberman Kenneth (Chief Operating Officer) Option Ex 33,973 1.11 37,710
2013-11-26 Hoberman Kenneth (Chief Operating Officer) Sale 3,144 21.27 66,872
2013-11-26 Hoberman Kenneth (Chief Operating Officer) Option Ex 6,967 1.11 7,733
2013-11-25 Hoberman Kenneth (Chief Operating Officer) Sale 14,350 21.94 314,839
2013-11-25 Hoberman Kenneth (Chief Operating Officer) Option Ex 37,000 1.11 41,070
2013-11-25 Rowinsky Eric K (Chief Medical Officer) Sale 13,903 20.56 285,845
2013-11-22 Hoberman Kenneth (Chief Operating Officer) Sale 11,523 20.14 232,073
2013-11-22 Hoberman Kenneth (Chief Operating Officer) Option Ex 35,000 1.11 38,850
2013-05-30 Zuerblis Kenneth J (Director) Buy 900 16.38 14,742
2013-05-29 Zuerblis Kenneth J (Director) Buy 2,100 15.86 33,299
2013-01-29 Buchi J Kevin (Director) Buy 500 10.00 5,000

Insider trading activities including stock purchases, stock sales, and option exercises of STML listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Stemline Therapeutics Inc (symbol STML, CIK number 1264587) see the Securities and Exchange Commission (SEC) website.